Stockscreener 앱 받기
1.17
1.74%
0.02
시장 영업 전:
1.20
0.03
+2.56%
60 Degrees Pharmaceuticals Inc 주식(SXTP)의 최신 뉴스
60 Degrees Pharmaceuticals at H.C. Wainwright: babesiosis push in focus - Investing.com
SXTP: Label expansion for ARAKODA into babesiosis advances, with pivotal milestones expected by 2028 - TradingView
60 Degrees Pharmaceuticals at H.C. Wainwright: babesiosis push in focus By Investing.com - Investing.com India
SXTP: Label expansion for ARAKODA into babesiosis aims for regulatory milestones and launch by 2028 - TradingView
Price to earnings forward of 60 Degrees Pharmaceuticals, Inc. – BOATS:SXTPW - TradingView
60 Degrees Pharmaceuticals Flags Cash Runway Only Into Early October - minichart.com.sg
60 Degrees Pharmaceuticals Updates Strategy for Tick-Borne Diseases - TipRanks
60 Degrees Pharmaceuticals updates investor presentation outlining tafenoquine babesiosis sNDA path, Q2 results and July financing - TradingView
60 Degrees Pharma flags going-concern risk - Stock Titan
60 Degrees Pharmaceuticals to Present at H.C. Wainwright 28th Annual Global Investment Conference - Quiver Quantitative
60 Degrees Pharmaceuticals Announces Participation in H.C. Wainwright 28th Annual Global Investment Conference - Yahoo Finance
A pharmaceutical company will post a public presentation Sept. 11. Its management will meet investors in New York. - Stock Titan
60 DEGREES PHARMACEUTICALS, INC. SEC Filing (Aug 26, 2026) - Stock Titan
Degrees (SXTP) Q1 2026 Earnings: The EPS Result Is Below Expectation in the Latest Reading; Stock Move: The Stock Finishes Near Unchanged in Latest TradingRevenue Warning Signal - careplusvn.com
Degrees (SXTP) Snapshot: Closes with Little Net Change at $1.13 at the Close; Next Test: Price Remains Between $1.07 Support and $1.19 Resistance in the Current UpdateSentiment Divergence - vinanet.vn
Degrees (SXTP) Quarter in Focus: The Bottom-Line Figure Trails Its Comparison under the Current Snapshot; The Stock Finishes Near Unchanged in the Latest ReadingShare Dilution Risk - vinanet.vn
Analysts’ Opinions Are Mixed on These Healthcare Stocks: OmniAb (OABI), Bicycle Therapeutics (BCYC) and 60 Degrees Pharmaceuticals, Inc. (SXTP) - The Globe and Mail
H.C. Wainwright Maintains 60 Degrees Pharmaceuticals(SXTP.US) With Hold Rating - Moomoo
SXTP Q1 2026 Earnings: Widened Loss of -$1.28 Per Share Misses Estimates as Stock Declines 5.77%Margin Improvement Report - vinanet.vn
60 Degrees Pharmaceuticals (SXTP) Edges Higher, Holding Above $1.14 SupportOption Breadth - Vinanet
SXTP Q1 2026 Earnings: EPS Miss of 65.12% Exposes Pre-Revenue Pipeline Cost PressuresGross Profit Margin - vinanet.vn
60 Degrees Pharmaceuticals (SXTP) Edges Higher by 1.27% as Shares Test Key Resistance at $1.26Bollinger Band - vinanet.vn
60 Degrees Pharmaceuticals (NASDAQ: SXTP) files to register 1.77M resale shares from warrant deal - Stock Titan
60 Degrees Q2 revenue jumps 106% to $208K; loss widens - scanx.trade
ARAKODA maker reports about $2.4M Q2 loss with about $208K revenue - Stock Titan
60 Degrees Pharmaceuticals (SXTP) flags going concern risk as losses deepen - Stock Titan
60 Degrees Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
60 Degrees Pharmaceuticals, Inc. Revenue Breakdown – NASDAQ:SXTPW - TradingView
60 Degrees Pharmaceuticals Inc (SXTP) Stock News Today - TradingKey
60 Degrees Pharmaceuticals Shareholders Approve Key Governance Actions - The Globe and Mail
60 Degrees Pharmaceuticals Inc (SXTP) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
60 Degrees Pharmaceuticals (NASDAQ: SXTP) reports 2026 shareholder vote outcomes - Stock Titan
Lind Global Fund III (SXTP) discloses 5.45% stake with warrant conversion cap - Stock Titan
60 Degrees Pharmaceuticals Completes Private Placement to Raise Capital - TipRanks
60 Degrees Pharmaceuticals Raises $1.0 Million in Private Placement of Stock and Warrants - tradingview.com
60 Degrees Pharmaceuticals (NASDAQ: SXTP) raises $1M in warrant-backed private placement - Stock Titan
60 Degrees Pharmaceuticals issues Series A, Series B warrants exercisable at $1.49 in $1 million private placement - Bitget
SXTP Q1 2026 Earnings: Wider-Than-Expected Loss of $1.28 Per Share Sends Stock Down 16.11%Surprise Factor Analysis - careplusvn.com
60 Degrees Pharmaceuticals raises $1M in private placement By Investing.com - Investing.com Canada
60 Degrees Pharmaceuticals, Inc. Announces Private Placement Priced At-the-Market Under Nasdaq Rules - GlobeNewswire
60 Degrees Pharmaceuticals Announces Minimum Enrollment - GlobeNewswire
60 Degrees Pharmaceuticals Inc (SXTP) Balance Sheet - TradingKey
60 Degrees Pharmaceuticals Secures US Patent for Tafenoquine Lung Infection Treatment - scanx.trade
60 Degrees Pharmaceuticals Inc - TradingKey
60 Degrees Pharmaceuticals Inc (SXTP) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
60 Degrees Pharmaceuticals Inc (SXTP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
SXTP|60 Degrees Pharmaceuticals Inc|Price:1.140| - TradingKey
60 Degrees Pharmaceuticals Inc (SXTP) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
SXTP Q1 2026 Earnings: EPS Misses Estimates by Wide Margin as Revenue Remains UnreportedShare Dilution Risk - careplusvn.com
60 Degrees Pharmaceuticals (SXTP) Edges Lower as Stock Tests Key Support LevelsAscending Triangle - careplusvn.com
60 Degrees Pharmaceuticals, Inc. Revenue Breakdown – NASDAQ:SXTP - TradingView
Enterprise value to revenue forward of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTP - TradingView
60 Degrees Pharmaceuticals Inc (SXTP) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
60 Degrees Pharmaceuticals (SCTP) Proxy filing Summary - Quartr
60 Degrees Pharmaceuticals (SCTP) Registration Filing Summary - Quartr
SXTP Q1 2026 Earnings: Significant EPS Miss Amid Absence of RevenueProfit Recovery Report - dars.gov.et
60 Degrees Pharmaceuticals: FDA-Approved Malaria & Babesiosis Treatments, Clinical Pipeline, and Commercial Growth (2026 Investor Update) – Minichart - Minichart
60 Degrees updates strategy for ARAKODA and profitability - TipRanks
SXTP Q1 2026 Earnings: EPS Misses Expectations as Company Navigates Pre-Revenue PhaseDividend Increase Stocks - vinanet.vn
Frontier tech research, news & data - MLQ.ai
60 Degrees Pharmaceuticals Inc. (SXTP) Q1 2026 Earnings: EPS Misses Estimates by Wide MarginInterim Report - dars.gov.et
SXTP Q1 2026 Earnings: Wider-than-Expected Loss Sends Shares LowerPost-Earnings Reaction - dars.gov.et
Enterprise value to EBITDA forward of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTP - TradingView
60 Degrees Pharmaceuticals, Inc. Warranton 60 Degrees Ph Financial Disclosures & SEC Filings - TradingView
60 Degrees Pharmaceuticals (NASDAQ: SXTP) Files 8-K Report Detailing Company Updates and Security Information - Minichart
3.06%
2.55%
자본화:
|
볼륨(24시간):